Jan. 13, 2026 — AliveCor has received U.S. Food and Drug Administration (FDA) clearance for the next generation of KAI ...
Jan. 13, 2026 — Kestra Medical Technologies, a wearable medical device and digital healthcare company, has announced a ...
Medtronic has announced the commercial launch of the OmniaSecure defibrillation lead in the U.S., with first cases being ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
Jan. 8, 2026 — Compremium AG recently announced that the U.S. Food and Drug Administration (FDA) has granted ...
Jan. 12, 2026 — YorLabs, Inc., a medical technology company providing next-generation intracardiac imaging solutions for ...
Jan. 12, 202 — Abbott and AtaCor Medical have announced a collaboration to advance a next-generation investigational ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
Jan. 12, 2026 — HeartLung Corp. has announced U.S. Food and Drug Administration (FDA) clearance of AI-CVD, its AI ...
Jan. 6, 2026 — Millions of Americans living with heart failure are not receiving medications that have been proven for ...
Robotic Magnetic Navigation (RMN) emerged two decades ago as an alternative approach to performing complex ablation ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Jan. 9, 2026 — Effective January 1, 2026, Elucid's Plaque-IQ coronary plaque analysis has received a new Category I ...
Jan. 7, 2026 — UltraSight, a provider of AI-guided cardiac imaging workflows, has partnered with Jefferson Health, one ...
Jan. 6, 2026 — Cleerly, a leader in AI-based cardiovascular imaging, has announced that Aetna will begin covering ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Dec. 10, 2025 — Medtronic plc has announced the first commercial use of the Liberant thrombectomy system (Liberant) ...
Jan. 6, 2026 — W. L. Gore & Associates’ medical business (Gore) has announced the FDA approval of the Gore Viabahn ...
Jan. 6, 2026 — Stereotaxis, a supplier of surgical robotics for minimally invasive endovascular intervention, has ...
January 14, 2026
